{"id":"NCT01068158","sponsor":"Topaz Pharmaceuticals Inc","briefTitle":"A Study Comparing the Safety and Efficacy of 0.5% Ivermectin Cream to Placebo in Lice Infested Subjects","officialTitle":"A Double-Blind Randomized Study to Compare the Efficacy, Safety, and Local Tolerability of a 0.5% Ivermectin Cream Compared to a Topical Vehicle Control in Subjects With Pediculus Humanus Capitis Infestation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2010-06","completion":"2010-07","firstPosted":"2010-02-12","resultsPosted":"2012-04-04","lastUpdate":"2012-04-06"},"enrollment":371,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Head Lice"],"interventions":[{"type":"DRUG","name":"0.5% Ivermectin Cream","otherNames":[]},{"type":"DRUG","name":"Placebo control","otherNames":[]}],"arms":[{"label":"0.5% Ivermectin Cream","type":"EXPERIMENTAL"},{"label":"Vehicle control","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if 0.5% Ivermectin Cream is a safe and effective treatment for head lice infestations.","primaryOutcome":{"measure":"Percentage of Index Participants Who Were Lice-Free by Day 2 That Were Maintained Through Day 15 Post-treatment With Either Ivermectin or Placebo (Vehicle Control)","timeFrame":"Day 2 up to Day 15 post-application","effectByArm":[{"arm":"0.5% Ivermectin","deltaMin":71,"sd":null},{"arm":"Vehicle Control","deltaMin":19,"sd":null}],"pValues":[]},"eligibility":{"minAge":"5 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":14,"exclusionCount":12},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":["23113480"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":169},"commonTop":[]}}